RenovoRx, Inc. (RNXT)

RenovoRx Market Cap

RenovoRx has a market cap or net worth of $21.32 million as of April 18, 2024. Its market cap has decreased by -17.70% in one year.

• Market Cap: 21.32M
• Enterprise Value: 18.90M
• 1-Year Change: -17.70%
• Ranking: #4977
• Category: Nano-Cap
• Stock Price: $1.16

Market Cap Chart

Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $21.32M, a decrease of -68.95%. That is a compound annual growth rate of -35.75%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2024	20.10M	5.24%
Apr 16, 2024	19.10M	-1.55%
Apr 15, 2024	19.40M	-5.83%
Apr 12, 2024	20.60M	-5.50%
Apr 11, 2024	21.80M	7.92%
Apr 10, 2024	20.20M	1.51%
Apr 9, 2024	19.90M	1.02%
Apr 8, 2024	19.70M	1.03%
Apr 5, 2024	19.50M	-3.47%
Apr 4, 2024	20.20M	-5.16%
Apr 3, 2024	21.30M	1.91%
Apr 2, 2024	20.90M	-6.28%
Apr 1, 2024	22.30M	55.94%
Mar 28, 2024	14.30M	-3.38%
Mar 27, 2024	14.80M	6.47%
Mar 26, 2024	13.90M	-9.15%
Mar 25, 2024	15.30M	0.66%
Mar 22, 2024	15.20M	-3.18%
Mar 21, 2024	15.70M	1.95%
Mar 20, 2024	15.40M	0.65%
Mar 19, 2024	15.30M	7.75%
Mar 18, 2024	14.20M	0.71%
Mar 15, 2024	14.10M	-
Mar 14, 2024	14.10M	-20.79%
Mar 13, 2024	17.80M	-1.66%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Aileron Therapeutics	20.76M
Synlogic	20.62M
DermTech	20.50M
Lumos Pharma	20.43M
Vincerx Pharma	20.35M
Alaunos Therapeutics	19.86M
Aptose Biosciences	19.80M
Kala Pharmaceuticals	19.26M